Sir Bruce Keogh joins Dendrite’s Scientific Advisory Board

Dendrite Clinical Systems has announced the appointment of Sir Bruce Keogh (KBE FMedSci FRCS FRCP) to the company’s newly established Scientific Advisory Board. The Scientific Advisory Board has been created to provide unique advice and guidance to Dendrite’s management team by taking an objective look at our activities and sharing with us their experience and knowledge. This includes evaluating the scientific merit of projects, assessing progress and offering strategic input on the company’s priorities.

“We are delighted to welcome Bruce to our new Scientific Advisory Board, who has unparallelled experience in the international healthcare sector,” said Dr Peter Walton, Dendrite’s managing Director. “His expertise and knowledge will provide us with valuable insights into how we can enhance and improve our expanding software portfolio, as well as increase awareness of our company globally.”

Sir Bruce has had a distinguished international career as a cardiac surgeon. He developed a longstanding interest in clinical outcomes from working closely with Dendrite to establish a national database for adult cardiac surgery early in his surgical career.

He subsequently became chair of Cardiac Surgery at University College London and Director of Surgery at the Heart Hospital, before being appointed Medical Director of the National Health Service and Director General in the Department of Health (DoH), a role that later transferred to NHS England. During this period (2007-18) as the most senior doctor in the NHS he was had particular responsibility for the development and implementation clinical policy and strategy across the health service in England.

In the DoH, he was the Government sponsor for NICE, the Healthcare Commission and the National Patient Safety Agency. He has served on several boards including NHS England. He is currently Chair of the Birmingham Women’s and Children’s NHS Foundation Trust, he was knighted for Services to Medicine in 2003.